Victims of Success in Heart Failure
email article The field of heart failure (HF) has experienced a recent string of successes -- large clinical trials studying novel therapeutics with impressive efficacy. Multiple drugs that work via various mechanisms have been shown to reduce both mortality and morbidity in patients with HF with reduced ejection fraction (HFrEF). For those of us who provide care for these patients, we may soon have access to seven different classes of medications that can potentially help our patients. With so many tools expected to be at our disposal, the question for each of us clinicians will be h...